Clinical Trial Update: Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial conducted by Emory University evaluated abobotulinumtoxin A for chronic exertional compartment syndrome of the leg; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exertional Compartment Syndrome

Drugs mentioned

• Abobotulinumtoxin A (abobotulinumtoxin A)

Snippet

Sponsor: Emory University | Conditions: Compartment Syndrome of Leg | Phase 4 | Status: COMPLETED